
- Volume 0 0
GENERICS HELP DRIVE DOWN PLAN D Rx COSTS
Officials at the Centers for Medicare & Medicaid Services (CMS) are crediting the strong emphasis on cost-effective generic drugs with driving down the anticipated cost of Medicare Part D prescription drug coverage premiums for the coming year.
According to CMS, the actual average premium paid by beneficiaries for standard Part D coverage in 2008 will be roughly $25-an amount that is nearly 40 percent lower than originally projected when the benefit was established in 2003, and also lower than was projected earlier this year.
"Smart choices" have played a key role, according to CMS Acting Deputy Administrator Herb B. Kuhn. "Medicare drug benefit bids continue to be well below projections because of?increased generic usage," he said. Kuhn also credited "effective plan negotiation" for lower prices from pharmaceutical manufacturers, as well as "strong competition" among the drug plans themselves.
Articles in this issue
over 18 years ago
Actemra Found to Relieve RA Symptomsover 18 years ago
Zestra Reports Positive Results of OTC Feminine Arousal Fluidover 18 years ago
Trial of New Weight-loss Pill Leaves Patients Feeling Fullover 18 years ago
Oral Care Products and the Diabetic Patientover 18 years ago
FOLIC ACID REDUCES RISK OF STROKEover 18 years ago
FDA APPROVES UPDATED WARFARIN INFOover 18 years ago
FONDAPARINUX MAY BE OPTION FOR HITover 18 years ago
diabetes PRODUCT chartsover 18 years ago
Hyperthermia, Chemotherapy Aid High-risk Cancer Patientsover 18 years ago
High Blood Pressure: Getting the Most Out of Home MonitoringNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


























